The relationship between folate and erectile dysfunction has moved from the margins of nutritional medicine into a genuine area of clinical inquiry. Folate—the naturally occurring B9 vitamin found in leafy greens, legumes, and liver—and its synthetic form, folic acid, sit at the center of a biochemical pathway that governs vascular health, nitric oxide production, and endothelial function. Because an erection is fundamentally a vascular event, anything that impairs the lining of blood vessels can impair erectile capacity. A growing body of observational and interventional research suggests that low folate status is not merely a bystander in erectile dysfunction (ED) but may be a modifiable contributor worth measuring and addressing.
The Vascular Foundation of Erection
An erection depends on a coordinated hemodynamic sequence. Sexual stimulation triggers the release of nitric oxide (NO) from endothelial cells and nerve terminals within the penis. Nitric oxide activates guanylate cyclase, raising cyclic GMP, which relaxes the smooth muscle of the corpora cavernosa and allows blood to flood the erectile tissue. The entire process hinges on a healthy endothelium capable of producing adequate nitric oxide on demand.
When the endothelium is dysfunctional—as it commonly is in men with diabetes, hypertension, high cholesterol, or metabolic syndrome—nitric oxide bioavailability falls, and erectile rigidity suffers. This is why ED is frequently described as an early warning sign of systemic vascular disease. The same microvascular impairment that blunts penile blood flow also affects the coronary and carotid circulation. Understanding this shared biology is the key to understanding why a micronutrient like folate could plausibly influence erectile performance.
Homocysteine: The Missing Link
Folate's most consequential role in vascular health is its regulation of homocysteine, a sulfur-containing amino acid produced during methionine metabolism. Folate, together with vitamins B6 and B12, is required to convert homocysteine back into methionine. When folate is deficient, homocysteine accumulates in the blood, a condition known as hyperhomocysteinemia.
Elevated homocysteine is toxic to the endothelium. It promotes oxidative stress, uncouples endothelial nitric oxide synthase (eNOS), and reduces the availability of tetrahydrobiopterin, a cofactor essential for nitric oxide production. The net effect is diminished nitric oxide signaling and impaired vasodilation—precisely the mechanism that undermines erection. Several studies have documented that men with ED tend to carry higher homocysteine concentrations than their unaffected peers, and that homocysteine levels often correlate inversely with erectile function scores.
By lowering homocysteine and directly supporting eNOS function, adequate folate status may help preserve the vascular responsiveness that erections require. Clinical studies suggest this pathway is one of the more compelling nutritional targets in the ED landscape.
What the Observational Data Show
The association between folate status and erectile dysfunction has now been examined across multiple populations. In 2021, a systematic review and meta-analysis pooled six studies comprising 982 men with ED and 860 controls. The analysis found that serum folic acid levels were, on average, roughly 0.94 ng/mL lower in men with ED than in healthy comparison subjects, and it concluded that low folate was an independent risk factor for erectile dysfunction. The authors also noted that folic acid supplementation may have potentially positive effects in the treatment of ED.
Earlier single-center work pointed in the same direction. A 2016 case-control study reported that men with ED had significantly lower serum folic acid concentrations than controls and that folate levels tracked with the severity of erectile dysfunction as measured by validated questionnaires. More recent research has extended these findings to specific ED subtypes, with folic acid emerging as a useful indicator in arteriogenic (blood-flow-related) erectile dysfunction, the form most tightly linked to endothelial disease.
Observational data cannot establish causation, and some of these studies are modest in size. But the consistency of the signal—lower folate in men with ED, and lower folate with more severe ED—makes the association difficult to dismiss.
Evidence from Supplementation Trials
The more clinically meaningful question is whether adding folic acid changes outcomes. Here the interventional data, though limited, are encouraging, particularly when folate is paired with standard therapy.
A randomized, double-blind trial in men with type 2 diabetes and ED offers the clearest example. Eighty-three patients received tadalafil 10 mg every other day plus either folic acid 5 mg daily or placebo for three months. Both groups improved, as expected with a PDE5 inhibitor, but the folic acid group improved substantially more. Mean International Index of Erectile Function (IIEF) scores rose from 11.65 to 16.80 with folic acid, versus 12.70 to 14.37 with placebo—a between-group difference that reached statistical significance (P = 0.002). The change in IIEF was roughly three times larger in the folic acid arm. Importantly, the combination was well tolerated, with no safety concerns attributable to folate.
Separate work in men with vasculogenic ED has shown that folic acid supplementation reduces circulating homocysteine while improving erectile function scores, reinforcing the proposed mechanism. Broader cardiovascular research provides supporting context: meta-analyses of randomized trials have found that folic acid supplementation improves flow-mediated dilation, a direct measure of endothelial function, in adults with and without established vascular disease.
The picture that emerges is not that folate is a standalone cure but that it may act as a vascular adjunct—supporting the endothelial machinery that ED treatments ultimately depend on. Some men, particularly those with metabolic disease or documented low folate, appear to experience meaningful benefit.
Who Might Benefit and How to Approach It
Folate status is easy to measure and inexpensive to correct, which makes it a reasonable consideration in a comprehensive ED workup. Men most likely to be folate-insufficient include those with poor dietary intake of leafy vegetables, heavy alcohol consumption (which impairs folate absorption and metabolism), certain genetic variants affecting folate processing, and those taking medications that interfere with folate, such as metformin or methotrexate.
Dietary folate should be the foundation: spinach, asparagus, Brussels sprouts, lentils, chickpeas, and fortified grains are all rich sources. For men with confirmed low levels or coexisting metabolic disease, supplemental folic acid—typically studied in the 0.5 to 5 mg daily range—has a strong safety record. It is worth emphasizing that folate is not a substitute for evaluating the underlying vascular and hormonal drivers of ED. High homocysteine, low folate, and erectile dysfunction are often all downstream of the same lifestyle and metabolic factors, so addressing diet, physical activity, blood pressure, glucose, and lipids remains central.
Anyone considering supplementation should do so under medical guidance. Very high folic acid intake can mask vitamin B12 deficiency, and the goal is repletion to a healthy range rather than indiscriminate megadosing. As always, ED that appears suddenly or progresses warrants a proper evaluation, because it can be the first sign of cardiovascular disease.
Conclusion
Folate sits at a biochemical crossroads that matters for erectile function: it lowers homocysteine, supports nitric oxide synthesis, and helps maintain the endothelial health on which erections depend. Observational studies consistently link low folate to erectile dysfunction, and early randomized trials suggest that folic acid can enhance the response to PDE5 inhibitor therapy, especially in men with metabolic disease. The evidence is still maturing, but the biological rationale is coherent and the intervention is low-risk. For men working to protect both vascular and sexual health, ensuring adequate folate—through diet first, and supplementation where appropriate—is a sensible, evidence-aligned step. You can explore more on these topics across the OnyxMD blog.
If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans—including the daily dual-PDE5 formulation EPIQ CHEWS—starting with a free online assessment at questionnaire.getonyxmd.com.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
Zhang Y, Zhang W, Dai Y, Jiang H, Zhang X. Serum Folic Acid and Erectile Dysfunction: A Systematic Review and Meta-Analysis. Sexual Medicine. 2021;9(3):100356. doi:10.1016/j.esxm.2021.100356
Karabakan M, Erkmen AE, Guzel O, Aktas BK, Bozkurt A, Akdemir S. Association between serum folic acid level and erectile dysfunction. Andrologia. 2016;48(5):532-535. doi:10.1111/and.12474
Hamidi Madani A, Asadolahzade A, Mokhtari G, Shakiba M, Farzan A, Esmaeili S. Assessment of the Efficacy of Combination Therapy With Folic Acid and Tadalafil for the Management of Erectile Dysfunction in Men With Type 2 Diabetes Mellitus. The Journal of Sexual Medicine. 2013;10(4):1146-1150. doi:10.1111/jsm.12047
Wang Y, Zhao W, Wang X, et al. Serum folic acid: an effective indicator for arteriogenic erectile dysfunction. Frontiers in Endocrinology. 2023;14:1080188. doi:10.3389/fendo.2023.1080188
Asemi Z, Karamali M, Esmaillzadeh A. The effects of folic acid supplementation on endothelial function in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutrition Journal. 2023;22:8. doi:10.1186/s12937-023-00834-z
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.